Fleischlauer J
Pharmakopsychiatr Neuropsychopharmakol. 1976 Nov;9(6):332-6.
20 non-psychotic aged (more than 60 years old) in-patients with behavior troubles were treated with pimozide in an open study for more than 12 weeks. Such symptoms deriving from the emotional sphere, mainly the aggressivity, had the best improvement rate. Together with this could also be seen an improvement of the social behavior. The dosage optimum was between 3 and 4 mg p.d., the improvement period seems to reach from the second to the eighth week. Extrapyramidal side-effects were rare, two patients developed, after more than nine months of therapy and long after the study had finished, a tardive hyperkinesia which was reversible after the withdrawal of the substance.
在一项开放研究中,对20名年龄在60岁以上、有行为问题的非精神病住院患者使用匹莫齐特进行了超过12周的治疗。源于情感领域的此类症状,主要是攻击性,改善率最佳。与此同时,社交行为也有所改善。最佳剂量为每日3至4毫克,改善期似乎从第二周持续到第八周。锥体外系副作用很少见,两名患者在治疗九个多月后且研究结束很久后出现了迟发性运动障碍,停药后这种症状可逆转。